كندا - الإنجليزية - Health Canada

pharmascience inc - desmopressin acetate (desmopressin acetate trihydrate) - tablet - 0.1mg - desmopressin acetate (desmopressin acetate trihydrate) 0.1mg - pituitary

كندا - الإنجليزية - Health Canada

pharmascience inc - desmopressin acetate (desmopressin acetate trihydrate) - tablet - 0.2mg - desmopressin acetate (desmopressin acetate trihydrate) 0.2mg - pituitary

مالطا - الإنجليزية - Medicines Authority

ferring ireland limited united drug house, magna drive magna business park, citywest road dublin 24 , ireland - desmopressin acetate - nasal drops, solution - desmopressin acetate 100 µg/ml - pituitary and hypothalamic hormones and analogues

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 0.2 mg - desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. desmopressin acetate is ineffective for the treatment of nephrogenic diabetes insipidus. patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. desmopressin acetate tablets are indicated for the management of primary nocturnal enuresis. desmopressin acetate may be used alone or as an adjunct to behavioral conditioning or other non-pharmacologic intervention. desmopressin acetate tablets are contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the components of desmopressin acetate tablets. desmopressin a

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

impax generics - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 0.1 mg - desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. desmopressin acetate is ineffective for the treatment of nephrogenic diabetes insipidus. patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. desmopressin acetate tablets are indicated for the management of primary nocturnal enuresis. desmopressin acetate may be used alone or as an adjunct to behavioral conditioning or other non-pharmacologic intervention. desmopressin acetate tablets are contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the components of desmopressin acetate tablets. desmopressin a

مالطا - الإنجليزية - Medicines Authority

ferring ireland limited united drug house, magna drive magna business park, citywest road dublin 24 , ireland - desmopressin acetate - solution for injection - desmopressin acetate 4 µg/ml - pituitary and hypothalamic hormones and analogues

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

bryant ranch prepack - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 0.2 mg - desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. desmopressin acetate tablets are ineffective for the treatment of nephrogenic diabetes insipidus. patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. desmopressin acetate tablets are indicated for the management of primary nocturnal enuresis. desmopressin acetate tablets may be used alone or as an adjunct to behavioral conditioning or other non-pharmacologic intervention. desmopressin acetate tablets are contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the components of desmopressin acetate tablet

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

ferring ireland ltd - desmopressin acetate - tablet - 0.1 milligram(s) - vasopressin and analogues; desmopressin

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

ferring ireland ltd - desmopressin acetate - solution for injection - 4 microgram(s)/millilitre - vasopressin and analogues; desmopressin

كندا - الإنجليزية - Health Canada

nu-pharm inc - desmopressin acetate - metered-dose pump - 0.1g - desmopressin acetate 0.1g - pituitary